Cefovecin

Cefovecin
Cefovecin.svg
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG

Cefovecin is a broad-spectrum antibiotic belonging to the cephalosporin class, specifically designed for use in veterinary medicine. It is commonly used to treat bacterial infections in dogs and cats.

Pharmacology

Cefovecin is a third-generation cephalosporin, which means it has a broad spectrum of activity against both Gram-positive and Gram-negative bacteria. It works by inhibiting bacterial cell wall synthesis, leading to cell lysis and death.

Administration and Dosage

Cefovecin is administered via subcutaneous injection, typically at a dose of 8 mg/kg. Its long half-life allows for a single injection to provide therapeutic levels for up to 14 days, making it convenient for treating infections in animals that are difficult to medicate orally.

Indications

Cefovecin is indicated for the treatment of skin infections, urinary tract infections, and soft tissue infections in dogs and cats. It is particularly useful in cases where compliance with oral medication is a concern.

Side Effects

Common side effects of cefovecin include mild gastrointestinal upset, such as vomiting and diarrhea. In rare cases, allergic reactions may occur, which can manifest as anaphylaxis or skin reactions.

Mechanism of Action

Cefovecin binds to penicillin-binding proteins (PBPs) located inside the bacterial cell wall, disrupting the synthesis of peptidoglycan, an essential component of the bacterial cell wall. This leads to the weakening of the cell wall and ultimately causes bacterial cell death.

Resistance

As with other antibiotics, the use of cefovecin can lead to the development of antibiotic resistance. It is important to use this medication judiciously and only when prescribed by a veterinarian.

Related pages

• Cephalosporin
• Antibiotic resistance
• Veterinary medicine

• 
  Cefovecin